Iris BioTechnologies Inc. (IRSB.OB) Awarded Two New Canadian Patents
Iris BioTechnologies Inc., a life sciences company, announced yesterday that they received two new Canadian patents. Their patent portfolio now consists of four Canadian patents, four United States patents, and many other patents in the European Union, Asia, Australia, and New Zealand. The Company accurately determines the optimal medical solution for each individual patient through a proprietary informatics system called BioWindows™. They accomplish this by categorizing individuals according to their molecular signatures and personal profiles. One of the patents granted to Iris BioTechnologies protects the Company's Nano-Biochip™ enabling the use of probes with superior binding affinity and specificity to undergo…